According to Syros Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.4825. At the end of 2024 the company had a P/S ratio of 139.
Year | P/S ratio | Change |
---|---|---|
2024 | 139 | 581.21% |
2023 | 20.4 | 317.88% |
2022 | 4.88 | -43.24% |
2021 | 8.60 | -78.73% |
2020 | 40.4 | -73.27% |
2019 | 151 | 64.8% |
2018 | 91.7 | -60.52% |
2017 | 232 | -74.09% |
2016 | 897 |